Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP217894.RAbvB0n4fOULvYj9FW0x-gUCJ0Oabdr6FAszYlMqcFLWE130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217894.RAbvB0n4fOULvYj9FW0x-gUCJ0Oabdr6FAszYlMqcFLWE130_provenance.
• NP221927.RAYudejZQ1RRCSVNEOzNKmdkoAnl5aaPD9Jig0vAeWS00130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221927.RAYudejZQ1RRCSVNEOzNKmdkoAnl5aaPD9Jig0vAeWS00130_provenance.
• NP1000918.RARKJ_mGUHMoIOM3nke_XHS1RyWbGbDOIn0liL_rZY2ls130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1000918.RARKJ_mGUHMoIOM3nke_XHS1RyWbGbDOIn0liL_rZY2ls130_provenance.
• NP946674.RAckLqAu2p8ecEYcoTxaHlP2kidMEuL1cW85CaQCQD6Go130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946674.RAckLqAu2p8ecEYcoTxaHlP2kidMEuL1cW85CaQCQD6Go130_provenance.
• NP946676.RAT79H5XxvdYf-wSWb3PfGjwe6LWIyAd1zzMrStqiVwnk130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946676.RAT79H5XxvdYf-wSWb3PfGjwe6LWIyAd1zzMrStqiVwnk130_provenance.
• NP990375.RACOx4lZWrrMBHxz7zMXTXgtzkX0BKsOXkDjMQs7xwOTw130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP990375.RACOx4lZWrrMBHxz7zMXTXgtzkX0BKsOXkDjMQs7xwOTw130_provenance.
• assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP221980.RAhFwzdNWdVnwoP1PY0fRjLMQz35j83R4-oXf1HwnQouA130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221980.RAhFwzdNWdVnwoP1PY0fRjLMQz35j83R4-oXf1HwnQouA130_provenance.
• NP946679.RABk5esWzQw5V9X5q3w6i5ovNlXhdxS1NDy7-5iXb5MKc130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946679.RABk5esWzQw5V9X5q3w6i5ovNlXhdxS1NDy7-5iXb5MKc130_provenance.
• NP946680.RAB8IOLstOhJ8jIsVlfxYJB1FQe07Hu9ovEufXW37YQd0130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946680.RAB8IOLstOhJ8jIsVlfxYJB1FQe07Hu9ovEufXW37YQd0130_provenance.
• NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_provenance.
• NP946677.RAtu004ocqy69USbMk95PEv_bvm7gA9d-KXNMSHtPoYzM130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946677.RAtu004ocqy69USbMk95PEv_bvm7gA9d-KXNMSHtPoYzM130_provenance.
• NP946678.RAhqdNFKRCScjhqHcupdL2dzyqFSs8XFyGCXiWU0O-Ubk130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946678.RAhqdNFKRCScjhqHcupdL2dzyqFSs8XFyGCXiWU0O-Ubk130_provenance.
• NP986603.RAKGaXUfOeSW5SG7FLeWRDd_0M9-pWHSXxtHcb0s87eQ0130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986603.RAKGaXUfOeSW5SG7FLeWRDd_0M9-pWHSXxtHcb0s87eQ0130_provenance.
• NP1004694.RA9I05k2HIn4egtpOjnp_G09BQhEmJAef1Bi0i1NpskeQ130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1004694.RA9I05k2HIn4egtpOjnp_G09BQhEmJAef1Bi0i1NpskeQ130_provenance.
• NP946672.RAFSHhra8ozCymRZ7waNgChRMazzCwgZzI3-IKCAvUyMo130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946672.RAFSHhra8ozCymRZ7waNgChRMazzCwgZzI3-IKCAvUyMo130_provenance.
• NP946675.RAFEAuSLSOYR1OoDcdNoDeYDdWXS1D3_HtTZhbetg54rM130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946675.RAFEAuSLSOYR1OoDcdNoDeYDdWXS1D3_HtTZhbetg54rM130_provenance.
• NP824212.RAzrgv9rrMyAHqCD_HrMlJH3V-yg2koY_a8HsW2TkUGCQ130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824212.RAzrgv9rrMyAHqCD_HrMlJH3V-yg2koY_a8HsW2TkUGCQ130_provenance.
• NP864358.RAxj9lD5D0sVSEOY3bojBbgxf2YY_hPepXmz-FyCcv3lQ130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864358.RAxj9lD5D0sVSEOY3bojBbgxf2YY_hPepXmz-FyCcv3lQ130_provenance.